Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 2,667 in Johnson and Johnson

  1. Digging For Dividends And ValueRead the original story w/Photo

    3 hrs ago | Seeking Alpha

    The last two years may have been frustrating for dividend-minded investors looking to accumulate their favorite stocks. Most investors have no doubt watched their favorite dividend stocks climb higher and higher until it just didn't make sense to keep buying.

    Comment?

  2. Johnson & Johnson: An Excellent 3% Dividend Choice For Risk-Averse Income InvestorsRead the original story w/Photo

    3 hrs ago | Seeking Alpha

    Recent U.S. dollar strength is not as big an issue for Johnson & Johnson as investors are made to believe. Stable sales and dividend growth throughout different markets actually make Johnson & Johnson a low-risk dividend investment for risk-conscious investors.

    Comment?

  3. Big Blue Reveals 1Q EPS Beat, Revenue DeclineRead the original story w/Photo

    5 hrs ago | Fox News

    International Business Machines Corp. reported a 12% decrease in revenue--the company's twelfth-straight quarter of year-over-year declines--hurt by the stronger U.S. dollar and weakness in its hardware business. For the year, the company reiterated its estimate for per-share profit, excluding certain items, between $15.75 and $16.50.

    Comment?

  4. Johnson & Johnson to Host Pharmaceutical Business ReviewRead the original story

    8 hrs ago | Freshnews

    Johnson & Johnson will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m. on Wednesday, May 20, 2015 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m. Paul Stoffels, M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific Officer and Joaquin Duato, Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic Caruso, Vice President, Finance and Chief Financial Officer will provide opening remarks.

    Comment?

  5. Are We Heading For A Profit Recession?Read the original story w/Photo

    7 hrs ago | Seeking Alpha

    As we enter deeper into first-quarter earnings season, we will likely soon find out whether aggregate earnings growth on the S&P 500 Index is heading for its first back-to-back quarterly contraction since September 2012. What makes the earnings slowdown more of a paradox is that dividend growth on the S&P continues to advance at a double-digit pace.1 Markets discount a tremendous amount of information, but ultimately, stock markets trade at a multiple of these two essential sources of income.

    Comment?

  6. Surging dollar rattles world economies and marketsRead the original story w/Photo

    9 hrs ago | Daily-Jeff.com

    The U.S. dollar hasn't been on a roll like this since Ronald Reagan sat in the White House and "Raiders of the Lost Ark" ruled the box office. Since June 30, the greenback is up 28 percent against the euro, 18 percent against the Japanese yen and 40 percent against the Brazilian real.

    Comment?

  7. J&J to increase wearable insulin patch-pump productionRead the original story w/Photo

    10 hrs ago | In-PharmaTechnologist.com

    Johnson & Johnson will scale up manufacturing of a three-day wearable patch pump used to deliver insulin, in preparation for a post 2016 launch. Calibra Medical was acquired by Johnson & Johnson in July 2012 , which added the device developer to its family of diabetes companies.

    Comment?

  8. New Report Available: Wound Care in ArgentinaRead the original story

    10 hrs ago | PR-inside.com

    Wound care is a category mainly related to sticking plasters/adhesive bandage, because these products have the most communication of their releases and innovations. The communication is targeted at mothers.

    Comment?

  9. 'How a Two-Pound Baby Changed the Direction of My Life'Read the original story w/Photo

    11 hrs ago | Switched

    This post is part of the Relay for Kids in partnership with SOS Children's Villages. Each time you share this post, Johnson & Johnson will donate $1 to support children worldwide affected by crisis.

    Comment?

  10. St. Jude Medical Is Acquiring Spinal Modulation for $215MRead the original story w/Photo

    12 hrs ago | Medical Device/Diagnostic Ind.

    After making a $40 million investment in 2013, St. Jude Medical is paying $175 million to bring Spinal Modulation, a neurostimulation company, within its fold. The Minnesota device maker is paying $175 million up front with a possibility of additional payments to acquire the company based in Menlo Park, California.

    Comment?

  11. One Put, One Call Option To Know About for Johnson & JohnsonRead the original story w/Photo

    12 hrs ago | Forbes.com

    Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the July expiration for JNJ.

    Comment?

  12. St. Jude to buy chronic pain treatment company for $ 215 millionRead the original story w/Photo

    12 hrs ago | Star Tribune

    St. Jude Medical in Little Canada is making a $215 million play in the market for treating chronic pain, a health condition that affects about 1.5 billion people worldwide. St. Jude on Monday announced it plans to exercise its right to buy Spinal Modulation, Inc., a Belgian company that makes a device to treat pain by electrically stimulating a cluster of sensory nerves called the dorsal root ganglion.

    Comment?

  13. Getting To Know Gain Theory, WPP's New Data Consultancy ShopRead the original story w/Photo

    13 hrs ago | AdExchanger.com

    Gain Theory, which has 200 people and a new office in New York City, rolls together two existing WPP agencies: the London-based marketing effectiveness agency Ohal and the Bangalore-based data analytics firm Meritus. Jason Harrison, previously CIO at Maxus, has been appointed CEO.

    Comment?

  14. Mylan plans $5 bn investment in Andhra PradeshRead the original story

    16 hrs ago | Newkerala.com

    Generic drug maker Mylan Laboratories Limited plans to invest $5 billion to expand its presence in Andhra Pradesh, a company official said on Monday. Rajeev Mukundan, Mylan's senior vice-president , informed Chief Minister N. Chandrababu Naidu that the company was looking at expanding its presence in the state with the additional investment.

    Comment?

  15. Coke Is Rock Solid Heading Into EarningsRead the original story w/Photo

    17 hrs ago | Seeking Alpha

    ... in emerging markets. In addition, just as we've seen with other large international companies like Johnson and Johnson (NYSE: JNJ ), we expect there to be some weakness in the company's results due to the strength we've seen in the dollar. Coke is ...

    Comment?

  16. ACP Recognizes Johnson & Johnson for its Commitment to VeteransRead the original story

    20 hrs ago | PRWeb

    "Johnson & Johnson is leading by example and I salute their efforts to support our nation's transitioning veterans," says Sid Goodfriend, ACP Founder and Chairman American Corporate Partners , a national nonprofit organization that connects post-9/11 veterans to business professionals for career guidance and mentorship, is pleased to announce the presentation of the 2015 ACP Award for Excellence in Veteran Engagement and Integration to Johnson & Johnson.

    Comment?

  17. When Tradition And Health Come Head-To-HeadRead the original story w/Photo

    21 hrs ago | Switched

    When I was just a few days old, I developed a burning fever accompanied by a terrible wail. My mother was worried.

    Comment?

  18. Athens' Noramco facility earns Manufacturer of the Year honorsRead the original story

    Sunday | Athens Banner-Herald

    Local pharmaceutical products manufacturer Noramco is this year's Manufacturer of the Year, claiming the award earlier this month at the annual Industry Appreciation Dinner hosted by the Athens-Clarke County Economic Development Department. More than 100 people, including local, state and national elected officials, community leaders and industry leaders from throughout the community, gathered at the recently renovated Cotton Press in the Chase Park Warehouses for the dinner.

    Comment?

  19. Dollar takes toll - Sun, 19 Apr 2015 PSTRead the original story w/Photo

    Sunday | The Spokesman-Review

    The U.S. dollar hasn't been on a roll like this since Ronald Reagan sat in the White House and "Raiders of the Lost Ark" ruled the box office. Since June 30, the greenback is up 28 percent against the euro, 18 percent against the Japanese yen and 40 percent against the Brazilian real.

    Comment?

  20. Public-private innovation hub aims to deliver innovation and growth...Read the original story w/Photo

    Saturday | Sunday Herald

    BioCity Scotland, the country's largest business park and incubator space for life sciences companies, is to launch a public-private innovation hub which aims to massively grow Scotland's life sciences sector by teaming together with bio-pharmaceutical and big data companies, Scotland's 16 universities, NHS Scotland and Scotland's eight innovation centres. BioCity Scotland, the country's largest business park and incubator space for life sciences companies, is to launch a public-private innovation hub which aims to massively grow Scotland's life sciences sector by teaming together with bio-pharmaceutical and big data companies, Scotland's 16 universities, NHS Scotland and Scotland's eight innovation centres.

    Comment?